A Phase II Study of Eribulin and Pembrolizumab in Soft Tissue Sarcomas

Malignant fibrous histiocytoma

Sintilimab for the Treatment of Locally Advanced, Metastatic, Recurrent, or Unresectable Undifferentiated Pleomorphic Sarcoma, SiARa Cancer Study Envafolimab And Envafolimab With Ipilimumab In Patients With Undifferentiated Pleomorphic Sarcoma Or Myxofibrosarcoma A Study of LY3435151 in Participants With Solid Tumors A Study of Pembrolizumab Plus Local Chemotherapy Using Isolated Limb Infusion (ILI) for Patients With Sarcoma in the Arm or Leg Talimogene Laherparepvec and Radiation Therapy in Treating Patients With Newly Diagnosed Soft Tissue Sarcoma That Can Be Removed by Surgery Study of DCC-3014 in Combination With Avelumab in Patients With Advanced or Metastatic Sarcomas ABBV-085, an Antibody Drug Conjugate, in Subjects With Advanced Solid Tumors Focused Ultrasound to Promote Immune Responses for Undifferentiated Pleomorphic Sarcoma Study of Anlotinib Hydrochloride and Toripalimab in Subjects With Unresectable or Metastatic Undifferentiated Pleomorphic Sarcoma Nivolumab With and Without Ipilimumab and Radiation Therapy in Treating Patients With Recurrent or Resectable Undifferentiated Pleomorphic Sarcoma or Dedifferentiated Liposarcoma Before Surgery A Phase II Study of Eribulin and Pembrolizumab in Soft Tissue Sarcomas